RR
Renu Rawat
About Renu Rawat
Data last updated:
Renu Rawat is a Director at Ambe Phytoextracts Private Limited (since 2019), Director at Hbmk Global Private Limited (since 2025) and Director at Hbmk Healthcare Private Limited (since 2022). The companies operate in FMCG and Pharma. The 3 current companies with reported revenue have a combined latest revenue of ₹66.55 Cr; the largest is Ambe Phytoextracts Private Limited at ₹52.25 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 22 Jan 2019 | 2007 | ₹52.25 Cr (FY 2025) | Active | |
| Director | 25 Nov 2025 | 2018 | ₹14.21 Cr (FY 2025) | Active | |
| Director | 18 Apr 2022 | 2016 | ₹9.2 Lakh (FY 2023) | Active |
Board colleagues of Renu Rawat
| Name | DIN | Company | Designation |
|---|---|---|---|
| Beena Singh | 02784409 | Ambe Phytoextracts Private Limited , Hbmk Global Private Limited and 1 more | Whole-Time Director |
| Harsh Pal Singh | 01327116 | Ambe Phytoextracts Private Limited , Hbmk Global Private Limited and 1 more | Managing Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Renu Rawat
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Renu Rawat
Renu Rawat currently holds 3 directorships: Ambe Phytoextracts Private Limited (Director, since 22 Jan 2019, revenue ₹52.25 Cr (FY 2025)); Hbmk Global Private Limited (Director, since 25 Nov 2025, revenue ₹14.21 Cr (FY 2025)); Hbmk Healthcare Private Limited (Director, since 18 Apr 2022, revenue ₹9.2 Lakh (FY 2023)).
Renu Rawat was first appointed on 22 Jan 2019 as Director at Ambe Phytoextracts Private Limited. The most recent appointment on record is 25 Nov 2025 at Hbmk Global Private Limited.
The 3 current companies of Renu Rawat that report revenue have a combined latest revenue of ₹66.55 Cr: Ambe Phytoextracts Private Limited ₹52.25 Cr (FY 2025); Hbmk Global Private Limited ₹14.21 Cr (FY 2025); Hbmk Healthcare Private Limited ₹9.2 Lakh (FY 2023).
The current boards of Renu Rawat's companies include Beena Singh (Ambe Phytoextracts Private Limited), Harsh Pal Singh (Ambe Phytoextracts Private Limited).